Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
BACKGROUND:Currently, there is inadequate evidence on which to base clinical management of neurotoxic snakebite envenoming, especially in the choice of initial antivenom dosage. This randomised controlled trial compared the effectiveness and safety of high versus low initial antivenom dosage in vict...
Main Authors: | Emilie Alirol, Sanjib Kumar Sharma, Anup Ghimire, Antoine Poncet, Christophe Combescure, Chabilal Thapa, Vijaya Prasad Paudel, Kalidas Adhikary, Walter Robert Taylor, David Warrell, Ulrich Kuch, François Chappuis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-05-01
|
Series: | PLoS Neglected Tropical Diseases |
Online Access: | http://europepmc.org/articles/PMC5446183?pdf=render |
Similar Items
-
Acute Severe Anaphylaxis in Nepali Patients with Neurotoxic Snakebite Envenoming Treated with the VINS Polyvalent Antivenom
by: Sanjib Kumar Sharma, et al.
Published: (2019-01-01) -
Antivenoms for Snakebite Envenoming: What Is in the Research Pipeline?
by: Emilie Alirol, et al.
Published: (2015-09-01) -
Fatal neurotoxic envenomation following the bite of a greater black krait (Bungarus niger) in Nepal: a case report
by: Deb Prasad Pandey, et al.
Published: (2016-07-01) -
Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
by: Abdulrazaq G Habib, et al.
Published: (2015-01-01) -
Cost-Effectiveness of Antivenoms for Snakebite Envenoming in 16 Countries in West Africa.
by: Muhammad Hamza, et al.
Published: (2016-03-01)